Bronchogen

Compound Overview

Research Use Only. Not for Human Consumption.

Bronchogen is supplied by Nexus as a sequence-defined short peptide bioregulator for controlled in-vitro research and analytical workflows. The sourced chemistry record identifies Bronchogen as Ala-Glu-Asp-Leu, abbreviated AEDL, a 4-residue synthetic peptide associated with bronchial and respiratory epithelial research models.

Bronchogen is categorized in the Nexus catalog under Russian Bioregulators. The current Nexus variant is a 20mg research-size vial under SKU BR20. The available source record supports its peptide sequence, molecular formula, calculated molecular weight, physical form, and storage guidance; it does not provide a confirmed CAS number, lot-specific purity value, salt or counter-ion assignment, batch number, or Certificate of Analysis values.

• Product: Bronchogen
• SKU: BR20
• Available Research Size: 20mg
• Class: Khavinson short peptide bioregulator
• Sequence: AEDL
• Sequence Display: Ala-Glu-Asp-Leu
• Physical Form: Lyophilized powder
• Use: For in-vitro research use only. Not for human consumption.

Research Background & Published Literature

The available Bronchogen literature base is concentrated in Russian and Eastern European bioregulator research. For this product record, the strongest usable chemistry anchor is the defined amino-acid sequence: Ala-Glu-Asp-Leu. That sequence provides the basis for the calculated molecular formula and molecular weight listed in the technical specifications below.

Researchers reviewing the literature around this compound can use the peer-reviewed resources below for additional context on mechanism of action, signaling pathways, and controlled laboratory research applications:

• Monaselidze et al. (2011) — Bull Exp Biol Med
• Kuzubova et al. (2015) — Bull Exp Biol Med
• Titova et al. (2017) — Ross Fiziol Zh Im I M Sechenova

Storage, Handling & Stability Guidelines

Store lyophilized Bronchogen material at -20°C, desiccated, and protected from light. These conditions are the only compound-specific storage parameters provided in the current research record.

After reconstitution, aliquot the material and avoid repeated freeze-thaw cycles. The source record does not specify a reconstitution solvent, working concentration, post-reconstitution hold time, or validated stability window, so those details should not be inferred from this page. Laboratories should document handling conditions according to their own validated internal procedures and preserve traceability between aliquots, source vial, and lot-level verification records.

Lab Verification

Nexus maintains a Lab Verified reference area for research-compound verification records. Where current lot documentation is available, HPLC may be used to review chromatographic purity and Mass Spectrometry may be used to support molecular identity confirmation.

No exact Bronchogen COA values are included in the current product record. This page therefore does not list a batch number, purity percentage, retention time, measured mass, salt form, counter-ion, or release-test result. The current research warning is to confirm final CAS, salt or counter-ion, purity, and mass values against the supplier COA before relying on a specific batch for analytical work.